Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23567936 | 0.86 | LMNA (0.39) | PIK3CDLMNA | |
| SCHEMBL25689707 | 0.83 | PIK3CD (0.46) | PIK3CD | |
| SCHEMBL21789877 | 0.83 | PIK3CD (0.46) | PIK3CD | |
| SCHEMBL22856338 | 0.82 | LMNA (0.41) | PIK3CDLMNA | |
| SCHEMBL26462130 | 0.82 | SLC22A1 (0.30) | — | |
| SCHEMBL22006593 | 0.82 | TSHR (0.31) | — | |
| SCHEMBL23568339 | 0.82 | LMNA (0.41) | PIK3CDLMNA | |
| SCHEMBL20835045 | 0.82 | PIK3CD (0.34) | PIK3CD | |
| SCHEMBL5948692 | 0.81 | TSHR (0.32) | — | |
| SCHEMBL25502105 | 0.80 | PIK3CD (0.38) | PIK3CDALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230305002-A1 | PROTEIN FOR RAPID, EFFICIENT CAPTURE OF ANTIGENS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-09-28 | — | — | US | disclosed |
| WO-2018059314-A1 | AZABICYCLE DERIVATIVES AND PREPARATION METHOD AND USE THEREOF | 四川科伦博泰生物医药股份有限公司 | 2018-04-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230305002-A1 | PROTEIN FOR RAPID, EFFICIENT CAPTURE OF ANTIGENS | CD2BP2, HSPBP1, CD74 | PIK3CD 3687/4885ALDH1A1 4709/4885LMNA 3504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.